Active Biomolecules from Vegetable Extracts with Antitumoral Activity against Pancreas Cancer: A Systematic Review (2011–2021)
Metadatos
Mostrar el registro completo del ítemAutor
Mesas Hernández, Cristina; Quiñonero Muñoz, Francisco José; Doello, Kevin; Perazzoli, Gloria; Cabeza Montilla, Laura; Prados Salazar, José Carlos; Melguizo Alonso, ConsolaciónEditorial
MDPI
Materia
Pancreatic cancer Plant extract Biomolecule Drug resistance Antitumor activity
Fecha
2022-11-02Referencia bibliográfica
Mesas, C... [et al.]. Active Biomolecules from Vegetable Extracts with Antitumoral Activity against Pancreas Cancer: A Systematic Review (2011–2021). Life 2022, 12, 1765. [https://doi.org/10.3390/life12111765]
Patrocinador
GranadaUniversity INB-009; Instituto de Salud Carlos III; European Commission DTS17/00081; Spanish Government RTC2019-006870-1; Junta de Andalucia P18-TP-1420 A-CTS-666-UGR20 B-CTS-122-UGR20; Ministerio de Educacion, Ciencia y Deporte y Competitividad (Spain) FPU17/02977 Ibs. GRANADAResumen
The emergence of resistance to pancreatic cancer (PC) current treatment requires the
development of new therapeutic strategies. In this context, bioactive molecules from plant extracts
have shown excellent properties to improve classical therapy against this type of tumor. This
systematic review aims to collect all the in vitro studies related to the antiproliferative activity of
isolated plant molecules that support their applicability in PC. A total of 620 articles published in the
last 10 years were identified, although only 28 were finally included to meet the inclusion criteria.
Our results reflect the most important biomolecules from natural compounds that induce cell death in
PC and their essential mechanism of cell death, including apoptosis, pathways activated by the KRAS
mutation and cycle cell arrest, among others. These in vitro studies provide an excellent molecule
guide showing applications against PC and that should be tested in vivo and in clinical trials to
determine their usefulness to reduce PC incidence and to improve the prognosis of these patients.
However, natural compounds are isolated in small amounts, which prevents comprehensive drug
screening, being necessary the role of organic synthesis for the total synthesis of natural compounds
or for the synthesis of their simplified and bioactive analogs.